{"transactions":[{"id":1453212,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-17T20:30:14.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026."},{"field":"security","element":"securityTitle","label":"F2","text":"This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-07-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-084294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024084294/ownership.xml","form_type":"4"}},{"id":1981708,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true}}],"security":"Warrants","published_at":"2023-03-02T14:20:24.000Z","date":"2023-02-28","kind":"other","acquired":true,"shares":19936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a member of Big Cypress Holdings LLC, and as part of the distribution received 19,936 warrants of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a member of Big Cypress Holdings LLC, and as part of the distribution received 19,936 warrants of the issuer."}],"balance_after":19936,"derivative":{"exercise_price":11.5,"exercise_date":"2022-01-14","expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":19936},"source":{"system":"sec-edgar","filing":"0001437749-23-005167","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923005167/rdgdoc.xml","form_type":"4"}},{"id":2091615,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Common Stock)","published_at":"2022-12-09T14:02:58.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":82987,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the \"Shares\") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance."}],"balance_after":82987,"derivative":{"exercise_price":1.08,"exercise_date":"2023-06-07","expiration_date":"2027-12-07","underlying":"Common Stock","underlying_shares":82987},"source":{"system":"sec-edgar","filing":"0001209191-22-060442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122060442/doc4.xml","form_type":"4"}},{"id":2091614,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-09T14:02:58.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":82987,"price":1.205,"value":99999.335,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the \"Shares\") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the \"Shares\") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance."}],"balance_after":394989,"source":{"system":"sec-edgar","filing":"0001209191-22-060442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122060442/doc4.xml","form_type":"4"}},{"id":2260907,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T21:52:37.000Z","date":"2022-05-20","kind":"other","acquired":true,"shares":299002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person received 207,001 shares as part of a pro-rata distribution by Big Cypress Holdings LLC, which the Reporting Person is a limited partner of, of which shares he previously had an indirect pecuniary interest.  Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13.  Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received 207,001 shares as part of a pro-rata distribution by Big Cypress Holdings LLC, which the Reporting Person is a limited partner of, of which shares he previously had an indirect pecuniary interest.  Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13.  Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."}],"balance_after":312002,"source":{"system":"sec-edgar","filing":"0001209191-22-031401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122031401/doc4.xml","form_type":"4"}},{"id":2550457,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":88932,"kind":"person","name":"Spragens Jeffrey G","position":1,"cik":"0001410620","reported_name":"Spragens Jeffrey G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T21:00:28.000Z","date":"2021-10-01","kind":"purchase","acquired":true,"shares":13000,"price":10.07,"value":130910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 13,000 shares of the issuer's common stock acquired by the reporting person in open market transactions."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001493152-21-024641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221024641/ownership.xml","form_type":"4"}}]}